Marriner Kirsten 4
4 · CLOROX CO /DE/ · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Marriner Kirsten
EVP - Chief People Officer
Transactions
- Sale
Common Stock
2025-03-10$153.46/sh−17$2,609→ 34,515 total - Sale
Common Stock
2025-03-10$152.64/sh−2,304$351,692→ 32,211 total - Sale
Common Stock
2025-03-10$151.53/sh−2,341$354,743→ 29,870 total - Sale
Common Stock
2025-03-10$150.85/sh−2,832$427,207→ 27,038 total - Sale
Common Stock
2025-03-11$150.00/sh−733$109,950→ 26,305 total
Footnotes (5)
- [F1]Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/9/2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]This transaction was executed in multiple trades at prices ranging from $153.46 to $153.465. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $152.29 to $153.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $151.275 to $152.045. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $150.26 to $151.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.